Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 6, 2003

View Archived Issues

CP-690550 prevents organ transplant rejection in monkeys

New KDR/Tie-2 kinase inhibitors in early development at Abbott

Schering AG claims novel inhibitors of carboxypeptidase B and their use in thrombotic disorders

New GluR5 antagonists and their use in pain and migraine

Novartis scientists identify new steryl-sulfatase inhibitors

New HC-PTP inhibitors and their use as wound-healing agents claimed by Ontogen

Novartis patent covers new inhibitors of PKC and IL-2 production

GlaxoSmithKline researchers prepare and test a new CCR3 antagonist

New antibacterial tetracyclines synthesized by Paratek team

BMP2 gene and variants linked to osteoporosis

Nexium i.v. provides faster and more effective acid control than pantoprazole

Berna grants HBsAg rights to Dynavax

Merger agreement between aaiPharma and CIMA terminated; CIMA to merge with Cephalon

Phase II results for HE-2200 fail to confirm earlier findings of cholesterol reduction

Kos and Takeda to copromote Niaspan and Advicor in U.S.

Roll-out of Forsteo across E.U.

Encouraging interim results from Alzhemed extension study

Grant supports research into antiaminophospholipid antibodies for Lassa fever

Pevion advances first vaccine into clinical testing

Ark Therapeutics granted patent for EG-009

Repligen evaluates subcutaneous dosage form of secretin

New European approval for Bondronat

YM BioSciences cleared to begin pivotal trial of tesmilifene

T-2639, a novel PAI-1 inhibitor, presented at AIMECS 03

Promising new agent for urinary incontinence discovered by Kyorin

Potent and selective inhibitor of human mast cell tryptase identified at Mochida

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...